Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 175

1.

Disruption of the CNTNAP2 gene in a t(7;15) translocation family without symptoms of Gilles de la Tourette syndrome.

Belloso JM, Bache I, Guitart M, Caballin MR, Halgren C, Kirchhoff M, Ropers HH, Tommerup N, Tümer Z.

Eur J Hum Genet. 2007 Jun;15(6):711-3. Epub 2007 Mar 28.

PMID:
17392702
[PubMed - indexed for MEDLINE]
Free Article
2.

CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder.

Verkerk AJ, Mathews CA, Joosse M, Eussen BH, Heutink P, Oostra BA; Tourette Syndrome Association International Consortium for Genetics.

Genomics. 2003 Jul;82(1):1-9.

PMID:
12809671
[PubMed - indexed for MEDLINE]
3.

Candidate region for Gilles de la Tourette syndrome at 7q31.

Kroisel PM, Petek E, Emberger W, Windpassinger C, Wladika W, Wagner K.

Am J Med Genet. 2001 Jul 1;101(3):259-61.

PMID:
11424142
[PubMed - indexed for MEDLINE]
4.

The Gilles de la Tourette syndrome: a principal component factor analytic study of a large pedigree.

Robertson MM, Cavanna AE.

Psychiatr Genet. 2007 Jun;17(3):143-52.

PMID:
17417057
[PubMed - indexed for MEDLINE]
5.

Genetic and clinical analysis of a large Dutch Gilles de la Tourette family.

Verkerk AJ, Cath DC, van der Linde HC, Both J, Heutink P, Breedveld G, Aulchenko YS, Oostra BA.

Mol Psychiatry. 2006 Oct;11(10):954-64. Epub 2006 Aug 8.

PMID:
16894393
[PubMed - indexed for MEDLINE]
6.
7.

The human contactin-associated protein-like 2 gene (CNTNAP2) spans over 2 Mb of DNA at chromosome 7q35.

Nakabayashi K, Scherer SW.

Genomics. 2001 Apr 1;73(1):108-12.

PMID:
11352571
[PubMed - indexed for MEDLINE]
8.

No evidence for genetic linkage of Gilles de la Tourette syndrome on chromosomes 7 and 18.

Heutink P, van de Wetering BJ, Breedveld GJ, Weber J, Sandkuyl LA, Devor EJ, Heiberg A, Niermeijer MF, Oostra BA.

J Med Genet. 1990 Jul;27(7):433-6.

PMID:
2395161
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Disruption of CNTNAP2 and additional structural genome changes in a boy with speech delay and autism spectrum disorder.

Poot M, Beyer V, Schwaab I, Damatova N, Van't Slot R, Prothero J, Holder SE, Haaf T.

Neurogenetics. 2010 Feb;11(1):81-9. doi: 10.1007/s10048-009-0205-1. Epub 2009 Jul 7.

PMID:
19582487
[PubMed - indexed for MEDLINE]
10.

Breakpoint sequences of an 1;8 translocation in a family with Gilles de la Tourette syndrome.

Matsumoto N, David DE, Johnson EW, Konecki D, Burmester JK, Ledbetter DH, Weber JL.

Eur J Hum Genet. 2000 Nov;8(11):875-83.

PMID:
11093278
[PubMed - indexed for MEDLINE]
Free Article
11.

A large Italian family with Gilles de la Tourette syndrome: clinical study and analysis of the SLITRK1 gene.

Fabbrini G, Pasquini M, Aurilia C, Berardelli I, Breedveld G, Oostra BA, Bonifati V, Berardelli A.

Mov Disord. 2007 Nov 15;22(15):2229-34.

PMID:
17712845
[PubMed - indexed for MEDLINE]
12.

Tourette syndrome in a pedigree with a 7;18 translocation: identification of a YAC spanning the translocation breakpoint at 18q22.3.

Boghosian-Sell L, Comings DE, Overhauser J.

Am J Hum Genet. 1996 Nov;59(5):999-1005.

PMID:
8900226
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Translocation breakpoint at 7q31 associated with tics: further evidence for IMMP2L as a candidate gene for Tourette syndrome.

Patel C, Cooper-Charles L, McMullan DJ, Walker JM, Davison V, Morton J.

Eur J Hum Genet. 2011 Jun;19(6):634-9. doi: 10.1038/ejhg.2010.238. Epub 2011 Mar 9.

PMID:
21386874
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The breakpoint identified in a balanced de novo translocation t(7;9)(p14.1;q31.3) disrupts the A-kinase (PRKA) anchor protein 2 gene (AKAP2) on chromosome 9 in a patient with Kallmann syndrome and bone anomalies.

Panza E, Gimelli G, Passalacqua M, Cohen A, Gimelli S, Giglio S, Ghezzi C, Sparatore B, Heye B, Zuffardi O, Rugarli E, Meitinger T, Romeo G, Ravazzolo R, Seri M.

Int J Mol Med. 2007 Mar;19(3):429-35.

PMID:
17273791
[PubMed - indexed for MEDLINE]
15.

[Gilles de la Tourette syndrome: a self-administered assessment questionnaire].

Usdin M, Mesnage V, Gonce M, Jedynak CP.

Rev Neurol (Paris). 2005 Sep;161(8-9):795-803. French.

PMID:
16244561
[PubMed - indexed for MEDLINE]
16.

Gilles de la Tourette syndrome.

Suchowersky O.

Can J Neurol Sci. 1994 Feb;21(1):48-52. Review.

PMID:
8180905
[PubMed - indexed for MEDLINE]
17.

Gilles de la Tourette syndrome is not linked to D2-dopamine receptor.

Gelernter J, Pakstis AJ, Pauls DL, Kurlan R, Gancher ST, Civelli O, Grandy D, Kidd KK.

Arch Gen Psychiatry. 1990 Nov;47(11):1073-7.

PMID:
1978653
[PubMed - indexed for MEDLINE]
18.

Translocation breakpoint in two unrelated Tourette syndrome cases, within a region previously linked to the disorder.

Crawford FC, Ait-Ghezala G, Morris M, Sutcliffe MJ, Hauser RA, Silver AA, Mullan MJ.

Hum Genet. 2003 Jul;113(2):154-61. Epub 2003 Apr 16.

PMID:
12698358
[PubMed - indexed for MEDLINE]
19.

Association of SLITRK1 to Gilles de la Tourette Syndrome.

Miranda DM, Wigg K, Kabia EM, Feng Y, Sandor P, Barr CL.

Am J Med Genet B Neuropsychiatr Genet. 2009 Jun 5;150B(4):483-6. doi: 10.1002/ajmg.b.30840.

PMID:
18698576
[PubMed - indexed for MEDLINE]
20.

Association study between Gilles de la Tourette Syndrome and two genes in the Robo-Slit pathway located in the chromosome 11q24 linked/associated region.

Miranda DM, Wigg K, Feng Y, Sandor P, Barr CL.

Am J Med Genet B Neuropsychiatr Genet. 2008 Jan 5;147B(1):68-72.

PMID:
17671968
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk